Specifically, the ARCL II phenotype includes developmental delays, skeletal abnormalities, a variable severity of cutis laxa (loose skin), and neurological abnormalities such as epilepsy, cognitive delay, and mental deterioration (Morava et al., 2009). The gene discussed is ATP6V0A2; the disease is Global developmental delay.